Bactfast® - Pathogen Stack for Bacterial Identification
Powered by AIoS™ and MMR™
Bactfast®
Bactfast® is a CE-IVDR–certified pan-bacterial identification solution built on Credence Genomics’ pathogen detection platform, a proprietary technology stack combining long-read sequencing, targeted metagenomics, and machine learning.
Designed for rapid, culture-independent diagnostics, Bactfast® enables comprehensive bacterial detection and predictive antimicrobial resistance insights in less than 24 hours, supporting confident clinical decision-making when it matters most.
Integrated sequencing, machine learning, and advanced modelling — delivering precise, reproducible pathogen insights.
Bactfast® uses 16S rRNA gene–based targeted metagenomic sequencing (tmNGS) to directly analyse bacterial DNA from clinical samples. Advanced bioinformatics and machine-learning algorithms ensure precise organism identification and resistance gene detection.
Coverage: 22,000+ bacterial organisms, includes genus and species-level identification
Regulatory Status: CE-IVDR certified
Bactfast® integrates seamlessly with other detection kits:
Request Product Access
Why Bactfast®?
In critical infections, time and accuracy save lives. Traditional culture-based methods are slow, limited, and often inconclusive, especially in patients who are already on antibiotics or infected with fastidious or unculturable organisms.
Agnostic Pathogen Detection
No prior assumptions required.
Culture-independent testing
Detects both culturable and unculturable bacteria.
Rapid turnaround time
Actionable results in <24 hours.
High accuracy and sensitivity
Up to 99% accuracy, operator-independent.
Comprehensive coverage
Entire known bacterial spectrum in one test.
Clinical Applications
Bactfast® is especially valuable in high-acuity and diagnostically challenging scenarios, including:
Non-resolving post-surgical infections
Prosthetic joint and valve infections
Deep tissue and sterile site infections
Sepsis and septic shock
Culture-negative infections
Chronic or recurrent infections
Immunocompromised patients
Post-transplant infections
Meningitis
Aligned with international guidelines
International guidelines increasingly recommend sequencing-based approaches in:
Culture-negative infections
Immunocompromised patients
Recurrent or unexplained infections
The Challenge
The Limitations of Traditional Bacterial Diagnostics
Delays in obtaining results can postpone targeted treatment, increasing the risk of complications in critical patients.
When infections go undetected by traditional methods, clinicians face diagnostic uncertainty that can compromise timely care.
Tests that miss less common or slow-growing organisms may result in incomplete diagnoses, hindering effective treatment decisions.
Tests that miss less common or slow-growing organisms may result in incomplete diagnoses, hindering effective treatment decisions.
Clinical Applications
Bactfast® is especially valuable in high-acuity and diagnostically challenging scenarios, including:
Aligned with international guidelines
International guidelines increasingly recommend sequencing-based approaches in:
The SOLUTION
How Bactfast® Delivers Diagnostic Clarity
Bactfast® uses next-generation sequencing and proprietary bioinformatics to rapidly identify bacterial pathogens with high specificity. Designed for complex and chronic cases, it delivers a complete diagnostic picture when traditional testing is inconclusive.
Metric | Bactfast® | Bacterial Culture | Filmarray and Bacterial PCR Panels | Insight |
|---|---|---|---|---|
Detection Approach
| Targeted metagenomic sequencing (16S rRNA) | Growth-based | Targeted amplification | Broad detection without organism pre-selection |
Organism Coverage
| 22,000+ bacterial species
| Limited (culturable organisms)
| Limited (panel-restricted)
| Comprehensive bacterial spectrum in a single test
|
Culture-Independent Detection
| Yes | No | Yes (with an exception in some molecular modalities where positive culture sample is required)
| Detects fastidious and unculturable bacteria
|
Detection in Culture-Negative Infections | High | None | Variable | Identifies infections missed by culture |
Mixed/Polymicrobial infections
| Clearly detected | Often missed | Partially detected | Resolves complex polymicrobial infections
|
Species-Level Resolution
| High (genus & species) | Variable | Variable | Enables confident clinical interpretation |
Turnaround Time
| <24 hours | 2–5 days
| 12–72 hours
| Faster results enable earlier targeted therapy
|
Sensitivity in Invasive Disease
| High | Variable | Moderate | Improved detection in low bacterial burden
|
Learn more about our pathogen detection stack and platform capabilities.
Faster, Broader, More Accurate Diagnostics
Bactfast® empowers clinicians with actionable insights by detecting a wide spectrum of bacterial pathogens—even those missed by traditional methods. With faster turnaround times and high concordance to culture-positive results, it provides reliable information that supports confident, timely treatment decisions. By combining broad coverage with precision analysis, Bactfast® transforms complex microbial data into clarity at the point of care.
Delivering Clear Results
Bactfast® delivers a complete diagnostic picture when traditional culture and targeted PCR panels may fall short.
Culture-independent detection helps identify pathogens sooner to support earlier, more confident clinical decisions.
Predictive intelligence adds clinical context that strengthens decision-making for critical care and complex infections.